Mark S. Eberhardt

15.0k total citations · 6 hit papers
69 papers, 11.0k citations indexed

About

Mark S. Eberhardt is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Mark S. Eberhardt has authored 69 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 11 papers in Surgery. Recurrent topics in Mark S. Eberhardt's work include Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Research (13 papers) and Diabetes and associated disorders (13 papers). Mark S. Eberhardt is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Research (13 papers) and Diabetes and associated disorders (13 papers). Mark S. Eberhardt collaborates with scholars based in United States, France and Australia. Mark S. Eberhardt's co-authors include Catherine C. Cowie, Katherine M. Flegal, Danita D. Byrd-Holt, Maureen I Harris, Sharon Saydah, Randie R. Little, Hsiao-Mei Wiedmeyer, David E. Goldstein, Elsie R. Pamuk and Linda S. Geiss and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Neurology.

In The Last Decade

Mark S. Eberhardt

68 papers receiving 10.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

1998 2.1k citations Katherine M. Flegal, Catherine C. Cowie et al. Diabetes Care profile →
Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population

2006 1.0k citations Catherine C. Cowie, Keith Rust et al. Diabetes Care profile →
Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006

2008 917 citations Catherine C. Cowie, Keith Rust et al. Diabetes Care profile →
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

2013 639 citations Mariana Lazo, Rubén Hernáez et al. American Journal of Epidemiology profile →
Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

1999 553 citations Catherine C. Cowie, Katherine M. Flegal et al. Diabetes Care profile →
Trends in Prevalence of Chronic Kidney Disease in the United States

2016 428 citations Daniel P. Murphy, Charles E. McCulloch et al. Annals of Internal Medicine profile →

Peers

Countries citing papers authored by Mark S. Eberhardt

Since Specialization

Citations

This map shows the geographic impact of Mark S. Eberhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Eberhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Eberhardt more than expected).

Fields of papers citing papers by Mark S. Eberhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Eberhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Eberhardt. The network helps show where Mark S. Eberhardt may publish in the future.

Co-authorship network of co-authors of Mark S. Eberhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Eberhardt. A scholar is included among the top collaborators of Mark S. Eberhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Eberhardt. Mark S. Eberhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in Prevalence of Chronic Kidney Disease in the United States breakdown → 2016 ·Annals of Internal Medicine ·Daniel P. Murphy, Charles E. McCulloch, Feng Lin, Tanushree Banerjee, Jennifer L. Bragg‐Gresham, Mark S. Eberhardt, Hal Morgenstern, Meda E. Pavkov, Rajiv Saran, Neil R. Powe, Chi‐yuan Hsu	428
2	Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994 breakdown → 2013 ·American Journal of Epidemiology ·Mariana Lazo, Rubén Hernáez, Mark S. Eberhardt, Susanne Bonekamp, Ihab R. Kamel, Eliseo Güallar, Ayman Koteish, Frederick L. Brancati, Jeanne M. Clark	639
3	Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B With Ultrasound-Defined Steatosis Based on Data From the Third National Health and Nutrition Examination Survey 2013 ·Clinical Gastroenterology and Hepatology ·Rubén Hernáez, Jody McLean, Mariana Lazo, Frederick L. Brancati, Joel N. Hirschhorn, Ingrid B. Borecki, Tamara B. Harris, Thutrang Nguyen, Ihab R. Kamel, Susanne Bonekamp, Mark S. Eberhardt, Jeanne M. Clark, Wen Hong Linda Kao, Elizabeth K. Speliotes	122
4	Nonsteroidal Anti-Inflammatory Drug Use Among Persons With Chronic Kidney Disease in the United States 2011 ·The Annals of Family Medicine ·Laura Plantinga, Vanessa Grubbs, Urmimala Sarkar, Chi‐yuan Hsu, Elizabeth Hedgeman, Bruce Robinson, Rajiv Saran, Linda S. Geiss, Nilka Rı́os Burrows, Mark S. Eberhardt, Neil R. Powe, (unknown)	92
5	Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes 2010 ·Clinical Journal of the American Society of Nephrology ·Laura Plantinga, Deidra C. Crews, Josef Coresh, Edgar R. Miller, Rajiv Saran, Jerry Yee, Elizabeth Hedgeman, Meda E. Pavkov, Mark S. Eberhardt, Desmond E. Williams, Neil R. Powe	290
6	Control of risk factors among people with diagnosed diabetes, by lower extremity disease status. 2009 ·PubMed Central ·Rashida Dorsey, Mark S. Eberhardt, Edward W. Gregg, Linda S. Geiss	9
7	Use of Complementary and Alternative Medicine Among Adults with Chronic Diseases: United States 2002 2006 ·The Journal of Alternative and Complementary Medicine ·Sharon Saydah, Mark S. Eberhardt	204
8	Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population breakdown → 2006 ·Diabetes Care ·Catherine C. Cowie, Keith Rust, Danita D. Byrd-Holt, Mark S. Eberhardt, Katherine M. Flegal, Michael M. Engelgau, Sharon Saydah, Desmond E. Williams, Linda S. Geiss, Edward W. Gregg	1002
9	Comparison of a single global item and an index of a multi-item health status measure among persons with and without diabetes in the US 2004 ·Quality of Life Research ·Ivan Barofsky, P.S. Erickson, Mark S. Eberhardt	15
10	Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease 2003 ·Epidemiology ·Bénédicte Stengel, Michelle Tarver-Carr, Neil R. Powe, Mark S. Eberhardt, Frederick L. Brancati	296
11	Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults 2003 ·American Journal of Kidney Diseases ·Thomas P. Erlinger, Michelle Tarver-Carr, Neil R. Powe, Lawrence J. Appel, Josef Coresh, Mark S. Eberhardt, Frederick L. Brancati	63
12	Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey 2002 ·American Journal of Kidney Diseases ·Camille A. Jones, Mildred E. Francis, Mark S. Eberhardt, Blanche M. Chavers, Josef Coresh, Michael M. Engelgau, John W. Kusek, Danita D. Byrd-Holt, K.M. Venkat Narayan, William H. Herman, Camara Phyllis Jones, Marcel E. Salive, Lawrence Y. Agodoa	328
13	Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States 2002 ·Journal of the American Society of Nephrology ·Michelle Tarver-Carr, Neil R. Powe, Mark S. Eberhardt, Thomas A. LaVeist, Raynard Kington, Josef Coresh, Frederick L. Brancati	229
14	Health, United States, 2001; with Urban and rural health chartbook 2001 ·Mark S. Eberhardt, (unknown), Sam Harper, Deborah D. Ingram, Diane M. Makuc, Elsie R. Pamuk, Kate Prager	286
15	Anthropometric measures and metabolic rate in association with risk of breast cancer (United States) 1996 ·Cancer Causes & Control ·(unknown), Mark S. Eberhardt, Angelo Turturro, R. Jean Hine	18
16	Report of the AAN Task Force on access to health care 1996 ·Neurology ·Michael P. Earnest, Jill M. Norris, Mark S. Eberhardt, George H. Sands	13
17	Differences in morbidity measures and risk factor identification using multiple data sources: The case of coronary heart disease 1995 ·Statistics in Medicine ·Jennifer H. Madans, Cynthia A. Reuben, (unknown), Mark S. Eberhardt	23
18	Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities 1994 ·Journal of Clinical Epidemiology ·Mark S. Eberhardt, (unknown), (unknown), Robert R. German, Steven M. Teutsch	46
19	Surveillance for diabetes mellitus--United States, 1980-1989. 1993 ·PubMed ·Linda S. Geiss, William H. Herman, Merilyn G. Goldschmid, Frank DeStefano, Mark S. Eberhardt, Earl S. Ford, Robert R. German, Jeffrey M. Newman, David R. Olson, Stephen J. Sepe	56
20	Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies? 1991 ·Diabetes Research and Clinical Practice ·Leslie A. O’Leary, Janice S. Dorman, Ronald E. LaPorte, Trevor J. Orchard, Dorothy J. Becker, L. H. Kuller, Mark S. Eberhardt, Druie Cavender, Bruce S. Rabin, Allan Drash	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact